Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
about
Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.Cancer vaccine: learning lessons from immune checkpoint inhibitors.Colorectal neoplasia differentially expressed: a long noncoding RNA with an imperative role in cancer.Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging
P2860
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@en
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@nl
type
label
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@en
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@nl
prefLabel
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@en
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@nl
P2093
P2860
P356
P1476
Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
@en
P2093
Wenting Shang
P2860
P304
P356
10.1002/MED.21455
P50
P577
2017-06-16T00:00:00Z